전세계 코로나 환자 100만명 넘어...사망자도 5만3천명<br /><br />Meanwhile, the number of coronavirus cases worldwide has climbed to more than one million.<br />The U.S., which has the most of any country, looks like it will soon ask people to wear face coverings of some kind when going out on public.<br />And, a glimpse of hope may be on the horizon. It appears researchers and drug companies are making progress on a vaccine.<br />Kim Ji-yeon reports.<br />More than a million cases of the coronavirus have been reported worldwide... and more than 53-thousand people have died from it,... according to latest figures from Johns Hopkins University.<br />As of Thursday, the U.S. had reported more than 245-thousand cases and a death toll of some six-thousand.<br />Soon, the U.S. government is expected to advise people to wear cloth masks or other materials to cover the face when going outside,... a shift in federal guidance amid concerns that the virus is being spread by infected people who show no symptoms.<br />The mayors of New York City and Los Angeles have urged residents to cover their faces already.<br />"We're advising New Yorkers to wear a face covering when you go outside and will be near other people. So let's be clear. This is a face covering. Again, we'll talk about the details in a moment, but it could be a scarf. It could be something you create yourself at home."<br />Countries with high numbers of COVID-19 fatalities, including Italy, Spain and France,... are considering the use of smartphone GPS data to bolster their quarantine efforts... despite their initial concerns about possible human rights abuses.<br />Meanwhile, researchers and drug companies around the world are completing the first stage of testing potential vaccines for COVID-19.<br />China Daily reports that a total of 108 volunteers have been inoculated with a vaccine prototype... in the first stage of tests approved last month.<br />They'll be monitored for six months looking for an antibody reaction.<br />And the U.S. company Moderna has announced plans to start phase two of human trials of a vaccine this spring.<br />Kim Ji-yeon, Arirang News.<br />
